Download Free Medical POLYPHARMACY PowerPoint Presentation

POLYPHARMACY PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Adverse Drug Events, which is titled "POLYPHARMACY", to know about the drugs and the elderly, pharmacodynamic and pharmacokinetic changes with aging, drug knowledge and compliance, and prudent prescribing.

Tags : Adverse Drug Events, POLYPHARMACY, elderly, pharmacodynamic, pharmacokinetic

Published on : Jul 20, 2021 | Views : 2714 | Downloads : 16

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

POLYPHARMACYWendolyn Gozansky, MD, MPHAssociate ProfessorDivision of Geriatric MedicineUniversity of Colorado Denver THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals. Leading change. Improving care for older adults. AGS
Slide 2-

CONTENTS Drugs and the elderly Pharmacodynamic and pharmacokinetic changes with aging Drug knowledge and compliance Prudent prescribing Slide 2
Slide 3-

Drug Use in the Elderly 12% of the population is aged 65+ Slide 3
Slide 4-

Drug Use in the Elderly 12% of the population is aged 65+ 30% of all prescription drug use is among those aged 65+ Slide 4
Slide 5-

Drug Use in the Elderly 12% of the population is age 65+ 30% of all prescription drug use is among those aged 65+ 50% of all OTC drug use is among those aged 65+ Slide 5
Slide 6-

ADVERSE DRUG REACTIONS (ADRs) 106,000 deaths in 1994 Slide 6
Slide 7-

ADVERSE DRUG REACTIONS (ADRs) 106,000 deaths in 1994 $177 billion in 2000 Slide 7
Slide 8-

ADVERSE DRUG REACTIONS (ADRs) 106,000 deaths in 1994 $177 billion in 2000 For every $1 spent on drugs, $1 spent on ADRs Slide 8
Slide 9-

ADVERSE DRUG REACTIONS (ADRs) 106,000 deaths in 1994 $177 billion in 2000 For every $1 spent on drugs, $1 spent on ADRs 95% of ADRs considered to be predictable Slide 9
Slide 10-

ADVERSE DRUG REACTIONS (ADRs) 106,000 deaths in 1994 $177 billion in 2000 For every $1 spent on drugs, $1 spent on ADRs 95% of ADRs considered to be predictable 7-fold increased risk in the elderly Related to polypharmacy Changes in pharmacodynamics/pharmacokinetics Drug-disease interactions Slide 10
Slide 11-

Exponential Relation Between Polypharmacy and ADRs Nolan L. JAGS. 1988;36(2):142-149. Slide 11
Slide 12-

CONTENTS Drugs and the elderly Pharmacodynamic and pharmacokinetic changes with aging Drug knowledge and compliance Prudent prescribing Slide 12
Slide 13-

Pharmacodynamics Response that occurs when a drug interacts at its receptor Slide 13
Slide 14-

Pharmacodynamic Changeswith Aging Increased response (eg, opiates) Slide 14
Slide 15-

Pharmacodynamic Changeswith Aging Increased response (eg, opiates) Decreased response (eg, beta-agonists) Slide 15
Slide 16-

Pharmacokinetics Drug concentration at the site of action Slide 16
Slide 17-

Pharmacokinetics Drug concentration at the site of action 4 determinants: Absorption Distribution Metabolism Elimination Slide 17
Slide 18-

PK Changes with Aging: ABSORPTION  gastric pH  gastric emptying  splanchnic blood flow  intestinal motility Minimal clinical importance Slide 18
Slide 19-

PK Changes with Aging: DISTRIBUTION  fat mass  muscle mass  total body water  albumin (binds acidic drugs)  alpha-1 glycoprotein (binds basic drugs) Clinically important Slide 19
Slide 20-

20-year-old woman Rosenberg, I. J Nutr. 1997. 127(5):990-991S. Published with permission.
Slide 21-

64-year-old woman 20-year-old woman Rosenberg, I. J Nutr. 1997. 127(5):990-991S. Published with permission.
Slide 22-

64-year-old woman 20-year-old woman Rosenberg, I. J Nutr. 1997. 127(5):990-991S. Published with permission.
Slide 23-

64-year-old woman 20-year-old woman Rosenberg, I. J Nutr. 1997. 127(5):990-991S. Published with permission.
Slide 24-

 hepatic mass  hepatic blood flow  first-pass metabolism Clinically important: Longer half-life of drugs undergoing phase I metabolism (eg, diazepam vs lorazepam) PK Changes with Aging:METABOLISM Slide 24
Slide 25-

 renal mass  renal blood flow  glomerular filtration rate Most clinically important  concentration of drugs dependent on renal clearance Serum creatinine alone does not provide adequate information to guide dosing PK Changes with Aging:ELIMINATION Slide 25
Slide 26-

Pharmacokinetic Changeswith Aging What is the best formula for estimating GFR in older adults? Cockcroft-Gault (CG) Modification of Diet in Renal Disease (MDRD) Slide 26
Slide 27-

CG vERSUS MDRD Slide 27
Slide 28-

CG VERSUS MDRD Slide 28
Slide 29-

Biology of the Patient Limited functional reserve Slide 29
Slide 30-

Biology of the Patient Disease Compensatory severity mechanisms Symptomatic Asymptomatic Resnick N.M, Marcantonio E.R. The Lancet. 1992;350(9085):1157-1158. Published with permission. Slide 30
Slide 31-

Biology of the Patient Limited functional reserve Drug-disease interactions Slide 31
Slide 32-

CONTENTS Drugs and the elderly Pharmacodynamic & pharmacokinetic changes with aging Drug knowledge and compliance Prudent prescribing Slide 32
Slide 33-

Do you know what’s in your patient’s medicine cabinet? ~20% of drugs found on home inventory were not revealed by physician interview Most frequently unreported class of drugs? Slide 33
Slide 34-

Slide 34
Slide 35-

Do you know what’s in your patient’s medicine cabinet? ~20% of drugs found on home inventory were not revealed by physician interview Most frequently unreported class of drugs? BENZODIAZEPINES!!! Slide 35
Slide 36-

Altered Compliance Under-utilization Over-utilization Enforced compliance Slide 36
Slide 37-

Relation Between Polypharmacyand Number of Prescribers Slide 37
Slide 38-

Relation Between Polypharmacyand Compliance Slide 38
Slide 39-

Methods to Improve Compliance  # of drugs, prescribers, and pharmacies Once-daily or twice-daily dosing Pill boxes Medication reminder charts  frequency of clinic visits Slide 39
Slide 40-

CONTENTS Drugs and the elderly Pharmacodynamic & pharmacokinetic changes with aging Drug knowledge and compliance Prudent prescribing Slide 40
Slide 41-

Avoid the Prescribing Cascade Drug 1 BMJ. 1997;315:1096-1099. Slide 41
Slide 42-

Avoid the Prescribing Cascade Drug 1 Adverse effect misinterpreted as new medical condition Rochon, P. BMJ. 1997;315:1096-1099. Published with permission. Slide 42
Slide 43-

Avoid the Prescribing Cascade Drug 1 Adverse effect misinterpreted as new medical condition Drug 2 Slide 43 Rochon, P. BMJ. 1997;315:1096-1099. Published with permission.
Slide 44-

Avoid the Prescribing Cascade HCTZ – Allopurinol NSAIDs – Antihypertensives Metoclopramide – Carbidopa/levodopa Cholinesterase inhibitors – Tolterodine Slide 44
Slide 45-

Beware of Drug-Drug Interactions (DDIs) 100% chance of DDIs with 8 drugs Slide 45
Slide 46-

Beware of Drug-Drug Interactions (DDIs) 100% chance of DDIs with 8 drugs Nearly 50% of community-dwelling geriatric patients had at least one DDI Slide 46
Slide 47-

Beware of Drug-Drug Interactions (DDIs) 100% chance of DDIs with 8 drugs Nearly 50% of community-dwelling geriatric patients had at least one DDI DDIs can result in ADRs or suboptimal dosing Slide 47
Slide 48-

Prudent Prescribing Principles Know your patients and their drug cabinets Slide 48
Slide 49-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Slide 49
Slide 50-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Understand biases in clinical trials Slide 50
Slide 51-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Understand biases in clinical trials Ask about compliance Slide 51
Slide 52-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Understand biases in clinical trials Ask about compliance Always include ADRs in the differential diagnosis of a new problem Slide 52
Slide 53-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Understand biases in clinical trials Ask about compliance Always include ADRs in the differential diagnosis of a new problem Try non-pharmacologic strategies Slide 53
Slide 54-

Prudent Prescribing Principles Know your patients and their drug cabinets Educate yourself and your patients Understand biases in clinical trials Ask about compliance Always include ADRs in the differential diagnosis of a new problem Try non-pharmacologic strategies Offer drug therapy when indicated Slide 54
Slide 55-

Which of the following is an age-related change that causes clinically significant alterations in drug pharmacokinetics? Decreased fat mass Increased gastric pH Decreased glomerular filtration rate Increased total body water Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 56-

Which of the following does not contribute to adverse drug reactions (ADRs) in the elderly? All prescriptions written by one provider Comorbid illness Hospitalization Increasing numbers of medications Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 57-

Which of the following is associated with improved medication compliance? Increasing numbers of medications Clinic visit in the previous 48 hours TID dosing Drug side effects Expensive medications Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 58-

Which of the following is a principle of prudent prescribing? Only inquire about prescribed medications Ask the patient, “What could possibly be so hard about taking pills every day?” Do not begin treatment without a diagnosis Use drugs before a trial of non-pharmacologic therapy Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 59-

Which of the following effects of aging contributes to an increased risk of ADRs related to benzodiazepine use? Increased body fat mass causing a greater volume of distribution and decreasing drug half-life Increased hepatic volume resulting in increased production of active metabolites Decreased renal function causing delayed renal excretion Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 60-

Patients who think they are taking too many medications report lower quality of life than patients who think they are taking the right number of medications. True False Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 61-

A patient with a serum creatinine of 0.5 mg/dL (within the normal range) will also have a normal creatinine clearance True False Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 62-

Older adults uniformly exhibit exaggerated pharmacodynamic responses compared with younger adults. True False Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 63-

Which of the following drugs is/are listed as “high-severity” potentially inappropriate medications for patients aged 65+? Amiodarone (Cordarone) Amitriptyline (Elavil) Cyclobenzaprine (Flexeril) Diazepam (Valium) Diphenhydramine (Benadryl) Indomethacin (Indocin) Ketorolac (Toradol) Nitrofurantoin (Macrodantin) All of the above Fick D.M, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 64-

Mark H. Beers, MD 19542009 Data from "Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts." Donna M. Fick, PhD, RN, et al. Arch Intern Med. 2003;163(22):2716-2724.
Slide 65-

Visit us at: Facebook.com/AmericanGeriatricsSociety Twitter.com/AmerGeriatrics www.americangeriatrics.org Thank you for your time! linkedin.com/company/american-geriatrics-society Slide 65